Dermatology

Latest News

Mental Health Comorbidities in Atopic Dermatitis: Essential Insights for Primary Care
Mental Health Comorbidities in Atopic Dermatitis: Essential Insights for Primary Care

November 20th 2025

Up to 1 in 4 patients with atopic dermatitis face anxiety or depression. Primary care clinicians are key to identifying risk and supporting mental well-being.

FDA Accepts sNDA for Roflumilast Cream 0.3% to Treat Plaque Psoriasis in Children Aged 2 to 5 Years
FDA Accepts sNDA for Roflumilast Cream 0.3% to Treat Plaque Psoriasis in Children Aged 2 to 5 Years

November 17th 2025

Tralokinumab Looks Promising to Treat Hand Involvement in Atopic Dermatitis
Tralokinumab Looks Promising to Treat Hand Involvement in Atopic Dermatitis

November 17th 2025

Tapinarof Cream 1%, Shows Early and Durable Response in Children With Atopic Dermatitis
Tapinarof Cream 1%, Shows Early and Durable Response in Children With Atopic Dermatitis

November 11th 2025

Treg-Targeting Rezpegaldesleukin Demonstrates Dual Benefit for Asthma and Atopic Dermatitis
Treg-Targeting Rezpegaldesleukin Demonstrates Dual Benefit for Asthma and Atopic Dermatitis

November 10th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.